SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

MARKSANS PHARMA

BSE: 524404 19 Aug 2025
Healthcare
₹ 184.45
Marksans Pharma Ltd. specializes in Pharmaceuticals within the Healthcare sector.

MARKSANS PHARMA - Share Price & Details

Market Cap
₹8,300
High /Low
359.0 / 168.0
Stock P/E
23.7
Book Value
₹54.4
Dividend Yield
0.43
ROCE
20.0
ROE
₹16.8
Face Value
1.0
PEG Ratio
0.87
EVEBITDA
₹14.1
Debt
322
CMP / FCF
103.0
Debt to equity
₹0.13
NP Ann
383
High price all time
359.0
Piotroski score
₹3.0
Graham Number
97.3
No. Eq. Shares
45.3
Net CF
₹92.5
Net profit
352
Price to book value
3.32
Interest Coverage
₹32.1
Low price all time
1.27
Industry PE
33.8
Reserves
₹2,422
Free Cash Flow
₹35.0

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
Shyama Computronics and Servic1.480.930.670.005.3335.5
Triochem Products Ltd.,3.25-4.52NA-18.440
MARKSANS PHARMA LTD.3217.44480.563197.341.068,30023.7
STRIDES PHARMA SCIENCE LIMITED5003.74133.474986.161.45802921.4
FDC LTD.6778.671221.916422.817.51778328.9

Peer Comparison Chart


About MARKSANS PHARMA

Marksans Pharma Ltd., with Security Code 524404, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Marksans Pharma gains 3% on UK MHRA approval for subsidiary; details here

(18 Aug 2025)
Marksans Pharma share price: Shares of pharmaceutical company Marksans Pharma were trading higher during intra-day deals on Monday,...
Read more →

marksans pharma rises as uk subsidiary gets approval for metformin prolonged release tablets

(18 Aug 2025)
The approval was granted by the UK regulatory authorities, allowing Relonchem to market the widely used anti-diabetic medication in three...
Read more →

Marksans Pharma Limited (NSE:MARKSANS) Analysts Are Reducing Their Forecasts For This Year

(15 Aug 2025)
NSEI:MARKSANS 1 Year Share Price vs Fair Value Explore Marksans Pharma's Fair Values from the Community and select...
Read more →

Marksans Pharma Ltd (BOM:524404) Q1 2026 Earnings Call Highlights: Navigating Growth Amidst ... By GuruFocus

(15 Aug 2025)
Marksans Pharma Ltd (BOM:524404) Q1 2026 Earnings Call Highlights: Navigating Growth Amidst ...
Read more →

Marksans Pharma Ltd leads losers in 'A' group

(13 Aug 2025)
Banco Products (India) Ltd, Astral Ltd, Praj Industries Ltd and Action Construction Equipment Ltd are among the other losers in the BSE's...
Read more →

Marksans Pharma reports Q1 FY26 gross profit 8.9% higher at Rs. 358.2 Cr

(13 Aug 2025)
Marksans Pharma Ltd. announced its unaudited financial results for the quarter ended June 30, 2025. The company reported revenue of Rs. 620...
Read more →

Company Updates